Evidence map›Paper›PMID 40133005›Full record

ArticleFunction (Oxford, England)2025

APOE4 Exerts Partial Diet-dependent Effects on Energy Expenditure and Skeletal Muscle Mitochondrial Pathways in a Preclinical Model.

Chelsea N Johnson, Colton R Lysaker, Elaine C Gast, Colin S McCoin, Riley E Kemna, Kelly N Z Fuller, Benjamin A Kugler, Edziu Franczak, Vivien Csikos, Julie Allen and 7 more

Abstract read
In one paragraph

Article in Function (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. FASEB bioAdvances · 2026
    Article
  2. Alzheimer's Disease Risk Factor APOE4 Exerts Dimorphic Effects on Female Bone.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Chelsea N JohnsonDepartment of Cell Biology and Physiology, University of Kansas Medical Center, Kansas City, KS 66160, USA.
Colton R LysakerUniversity of Kansas Alzheimer's Disease Research Center, University of Kansas Medical Center, Fairway, KS 66205, USA.
Elaine C GastDepartment of Cell Biology and Physiology, University of Kansas Medical Center, Kansas City, KS 66160, USA.
Colin S McCoinDepartment of Cell Biology and Physiology, University of Kansas Medical Center, Kansas City, KS 66160, USA.
Riley E KemnaUniversity of Kansas Alzheimer's Disease Research Center, University of Kansas Medical Center, Fairway, KS 66205, USA.
Kelly N Z FullerUniversity of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
Benjamin A KuglerDepartment of Cell Biology and Physiology, University of Kansas Medical Center, Kansas City, KS 66160, USA.
Edziu FranczakDepartment of Cell Biology and Physiology, University of Kansas Medical Center, Kansas City, KS 66160, USA.
Vivien CsikosUniversity of Kansas Alzheimer's Disease Research Center, University of Kansas Medical Center, Fairway, KS 66205, USA.
Julie AllenDepartment of Cell Biology and Physiology, University of Kansas Medical Center, Kansas City, KS 66160, USA.
Casey S JohnUniversity of Kansas Alzheimer's Disease Research Center, University of Kansas Medical Center, Fairway, KS 66205, USA.
MaryJane A WolfDepartment of Cell Biology and Physiology, University of Kansas Medical Center, Kansas City, KS 66160, USA.
Matthew E MorrisDepartment of Cell Biology and Physiology, University of Kansas Medical Center, Kansas City, KS 66160, USA.ORCID 0000-0001-7046-3623
John P ThyfaultDepartment of Cell Biology and Physiology, University of Kansas Medical Center, Kansas City, KS 66160, USA.ORCID 0000-0001-7920-7466
Heather M WilkinsUniversity of Kansas Alzheimer's Disease Research Center, University of Kansas Medical Center, Fairway, KS 66205, USA.
Paige C GeigerDepartment of Cell Biology and Physiology, University of Kansas Medical Center, Kansas City, KS 66160, USA.
Jill K MorrisUniversity of Kansas Alzheimer's Disease Research Center, University of Kansas Medical Center, Fairway, KS 66205, USA.ORCID 0000-0001-5911-4190

Funding

Mentoring CoreP20GM103418 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Douglas E Wright · 2012 to 2026
$63.0M
University of Kansas Alzheimer's Disease Research Center (KU ADRC)P30AG072973 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Mohammad Haeri · 2021 to 2026
$25.3M
Supplement for Google cloud build-outR24GM137786 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI Alan Tackett · 2020 to 2026
$15.4M
longitudinal assessment of stress and stress-related concepts across a behavioral weight loss interventionP20GM144269 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI John P Thyfault, STEVEN A WEINMAN · 2022 to 2026
$14.9M
Multidisciplinary Research Training Program in Alzheimer's Disease and Related DisordersT32AG078114 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Sandra A Billinger, Eric Dennis Vidoni · 2022 to 2026
$1.2M
Metabolic Phenotyping ClusterS10OD028598 · OD · UNIVERSITY OF KANSAS MEDICAL CENTER · PI THYFAULT, JOHN P · 2020 to 2020
$602k
National Institute of General Medicine P20GM144269NIA NIH HHS P30 AG072973NIA NIH HHS T32 AG078114NIGMS NIH HHS P20 GM103418NIGMS NIH HHS P20 GM144269NIGMS NIH HHS R24GM137786NIH HHS S10 OD028598University of Kansas Medical Center
6 · The paper itself

Abstract

Apolipoprotein E4 (APOE4) is the greatest genetic risk factor for Alzheimer's (AD) and is linked to whole-body metabolic dysfunction. However, it is unclear how APOE4 interacts with modifiable factors like diet to impact tissues central to regulating whole-body metabolism. We examined APOE4- and Western diet-driven effects in skeletal muscle using APOE3 (control) and APOE4 targeted replacement mice on a C57BL/6NTac background fed a high-fat diet (HFD, 45% kcal fat) or low-fat diet (LFD, 10% kcal fat) for 4 months (n = 7-8 per genotype/diet/sex combination). We assessed body composition and whole-body outcomes linked to skeletal muscle function including respiratory exchange ratio (RER) and resting energy expenditure (REE). In skeletal muscle, we evaluated the proteome and mitochondrial respiration. In males only, APOE4 drove greater gains in fat mass and lower gains in lean mass on both diets. APOE4 did not affect daily RER but was associated with elevated REE in males and lower REE in HFD females after covarying for body composition. Skeletal muscle proteomics showed APOE4 exerts several diet- and sex-specific effects on mitochondrial pathways, including elevations in branched-chain amino catabolism in HFD males and reductions in oxidative phosphorylation in LFD females. This did not translate to differences in skeletal muscle mitochondrial respiration, suggesting that compensatory mechanisms may sustain mitochondrial function at this age. Our work indicates that genetic risk may mediate early life effects on skeletal muscle mitochondria and energy expenditure that are partially dependent on diet. This has important implications for mitigating ad risk in APOE4 carriers.

Indexed as

Apolipoprotein E4Energy MetabolismMitochondria, MuscleMuscle, SkeletalAnimalsBody CompositionDiet, Fat-RestrictedDiet, High-FatDiet, WesternFemaleMaleMiceMice, Inbred C57BLMice, TransgenicApolipoprotein E4Alzheimer'sAPOE4micemitochondriaproteomicsskeletal musclewhole-body metabolism

Identifiers

PMID40133005
PMCPMC11980864

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.